News from American Society of Hematology A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 21, 2017, 12:48 ET New Antibody Uses One-Two Punch to Potentially Treat Blood Cancers

Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from...


Jun 19, 2017, 12:13 ET ASH to Develop Clinical Guidelines to Improve Care for People with Sickle Cell Disease

This World Sickle Cell Day, the American Society of Hematology (ASH) is working on several projects to conquer sickle cell disease (SCD)...


Jun 07, 2017, 13:49 ET Transplant Community & Sickle Cell Disease Advocates Urge Congress to Advance Policies Supporting Sickle Cell Disease Research and Treatment

The American Society for Blood and Marrow Transplantation (ASBMT), American Society of Hematology (ASH), American Society for Gene & Cell...


Jun 06, 2017, 12:00 ET Precision Therapy Enasidenib Effective in Treating Deadly Form of Leukemia

Some patients with relapsed or treatment-resistant acute myeloid leukemia, a form of blood cancer for which there are few treatments, may achieve...


Apr 17, 2017, 08:38 ET Medical Groups Unite in Support of Science

As the world's leading organizations representing clinicians, laboratory researchers, and physician-scientists committed to improving patient care,...


Apr 06, 2017, 10:00 ET ASH Awards $750k to Preserve Promising Biomedical Research

In 2012, the American Society of Hematology (ASH) committed to preserving blood disease research threatened by federal budget cuts to the National...


Feb 01, 2017, 11:47 ET Statement from ASH, AACR, AACI, ASTRO, ASPHO, and LUNGevity Foundation on the Administration's Executive Order on Immigration

As the world's leading organizations representing laboratory researchers, physician-scientists, clinicians, the nation's cancer centers, and...


Dec 06, 2016, 10:45 ET Highly Anticipated Late-Breaking Abstracts Session to Feature Groundbreaking Scientific Data During 58th ASH Annual Meeting

The American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood...


Dec 03, 2016, 15:00 ET Studies Advance a More Personalized Approach to Treatment

Studies being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego aim to bring a more...


Dec 03, 2016, 13:00 ET Sickle Cell Disease Research Shows Progress in Preventing Related Complications and Death

Sickle cell disease (SCD) is an inherited chronic disorder characterized by rigid, sickle-shaped red blood cells that get stuck in veins and block...


Dec 03, 2016, 11:00 ET Bioengineering Innovations Show Promise for Improving Treatments and Drug Delivery

In five studies being presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, researchers...


Nov 29, 2016, 17:17 ET American Society of Hematology Launches Digital, Open-Access Journal

Blood has led the way in experimental and clinical hematologic research as the flagship journal of the American Society of Hematology (ASH)....


Sep 06, 2016, 09:30 ET Report on Sickle Cell Disease Suggests That Current State of Treatment and Care is Inadequate and Improvements Are Needed

 Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem...


Jun 29, 2016, 10:17 ET American Society of Hematology Data Sharing Initiative to Be Featured at National Cancer Moonshot Summit Today

The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders,...


Jun 13, 2016, 12:32 ET Autologous Stem Cell Transplantation Offers Safe and Effective--and Potentially Curative - Option for Patients with HIV-Associated Lymphoma

 New research published online today in Blood, the Journal of the American Society of Hematology (ASH), challenges the generally held...


Mar 24, 2016, 10:49 ET ASH to Expand Family of Blood Journals with Launch of New Cutting-Edge Publication

The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited...


Mar 16, 2016, 10:24 ET Analysis of Outcomes of Hemophilia Care Over 50-Year Span Reveals Progress, Ongoing Disparities

 Despite significant advances in hemophilia therapies and increased access to integrated treatment centers over the last half century, men with...


Dec 06, 2015, 11:00 ET Targeted Blood Cancer Therapies Offer Significant Improvements in Survival, Increased Options for Patients

New, highly targeted treatment approaches for leukemia, lymphoma, and myeloma to be presented today at the 57th American Society of Hematology...


Dec 06, 2015, 09:00 ET New Sickle Cell Disease Research Shows Improved Patient Outcomes And Reduced Disease Burden

 Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes...


Dec 05, 2015, 10:30 ET Approaches to Supportive Care for Blood Disorders Improve Outcomes, Expand Access to Treatment

 New research to be presented today at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition provides new answers to...


Dec 05, 2015, 09:00 ET New Genomic Insights May Lead to More Personalized Approaches to Treatment of Pediatric Blood Diseases

 Research to be presented today at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition reveals genetic variants that...


Dec 05, 2015, 07:30 ET Experimental Gene Therapy Studies Show Promising Outcomes for Patients with Rare Blood Disorders and Cancer

New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's...


Feb 05, 2015, 10:00 ET Analysis: High-Cost Blood Cancer Drugs Deliver High Value

Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for...


Dec 07, 2014, 14:00 ET Studies Compare Blood Clot Treatments, Illuminate Recurrence Risk In High-Risk Groups

Studies presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition compare new and standard-of-care treatments for...


Dec 07, 2014, 12:30 ET Novel Combinations Of New And Existing Therapies Yield Promising Results for Leukemia Patients With Poor Prognoses

Recognizing that leukemia cannot be conquered with a "one-size-fits-all" approach, researchers are pursuing novel targeted therapies and...